We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Healthcare Services Group
HCSG
$1.44B
| $1.06M | ﹤0.01% |
62,306
-83,836
| -57% | -$1.45M |
|
|
ONIT
1402
Onity Group
ONIT
$328M
| $1.06M | ﹤0.01% |
38,621
+8,900
| +30% | +$209K |
|
|
MZTI
1403
The Marzetti Company
MZTI
$3.15B
| $1.06M | ﹤0.01% |
8,215
-1,402
| -15% | -$192K |
|
|
LGTY
1404
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $1.05M | ﹤0.01% |
65,201
+16,207
| +33% | +$280K |
|
1405
National Bank Holdings
NBHC
$1.92B
| $1.05M | ﹤0.01% |
27,428
-3,166
| -10% | -$123K |
|
1406
Unisys
UIS
$205M
| $1.05M | ﹤0.01% |
87,230
+57,089
| +189% | +$805K |
|
1407
Atlantic Union Bankshares
AUB
$6.02B
| $1.05M | ﹤0.01% |
30,888
-8,638
| -22% | -$299K |
|
1408
Moody's
MCO
$82.5B
| $1.05M | ﹤0.01% |
3,888
-20,729
| -84% | -$6.2M |
|
1409
Gold Fields
GFI
$36B
| $1.05M | ﹤0.01% |
114,808
-26,761
| -19% | -$320K |
|
1410
Methode Electronics
MEI
$595M
| $1.04M | ﹤0.01% |
28,152
-1,874
| -6% | -$80.8K |
|
1411
Turning Point Brands
TPB
$1.77B
| $1.04M | ﹤0.01% |
+38,358
| New | +$1.12M |
|
1412
TriNet
TNET
$3.06B
| $1.03M | ﹤0.01% |
13,328
-6,220
| -32% | -$520K |
|
1413
Nabors Industries
NBR
$1.3B
| $1.03M | ﹤0.01% |
7,711
+3,953
| +105% | +$619K |
|
|
UMH
1414
UMH Properties
UMH
$1.38B
| $1.03M | ﹤0.01% |
58,426
-925
| -2% | -$19.2K |
|
1415
Home BancShares
HOMB
$6.22B
| $1.03M | ﹤0.01% |
50,368
-204,949
| -80% | -$4.43M |
|
|
BRSL
1416
Brightstar Lottery PLC
BRSL
$2.07B
| $1.03M | ﹤0.01% |
55,290
-20,810
| -27% | -$443K |
|
1417
Innospec
IOSP
$2.31B
| $1.03M | ﹤0.01% |
10,706
-3,781
| -26% | -$368K |
|
1418
RCI Hospitality Holdings
RICK
$210M
| $1.02M | ﹤0.01% |
21,093
-111
| -0.5% | -$6.38K |
|
|
FOCS
1419
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $1.02M | ﹤0.01% |
29,945
-4,336
| -13% | -$166K |
|
|
FBMS
1420
DELISTED
The First Bancshares, Inc.
FBMS
| $1.02M | ﹤0.01% |
35,600
+17,255
| +94% | +$536K |
|
|
XYZ
1421
Block Inc
XYZ
$47.5B
| $1.01M | ﹤0.01% |
16,940
-27,710
| -62% | -$2.53M |
|
1422
Clearwater Paper
CLW
$366M
| $1.01M | ﹤0.01% |
29,968
-7,985
| -21% | -$250K |
|
1423
CBIZ
CBZ
$2.96B
| $1M | ﹤0.01% |
25,075
-654
| -3% | -$26.4K |
|
1424
Harmony Gold Mining
HMY
$12.2B
| $1M | ﹤0.01% |
320,022
-1,886,745
| -85% | -$7.26M |
|
1425
Calix
CALX
$2.49B
| $995K | ﹤0.01% |
29,555
-5,432
| -16% | -$202K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.